Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders
- PMID: 30851172
- DOI: 10.15403/jgld.2014.1121.281.syd
Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders
Abstract
Background and aims: Eosinophilic gastrointestinal disorders (EGIDs) have been linked with atopic conditions, connective tissue disorders, and autoimmunity, but the association between EGIDs and autonomic dysfunction has not been extensively described. We aimed to assess this association and determine the prevalence of autonomic dysfunction in our EGID population.
Methods: In this retrospective cohort study, we analyzed adult patients in the University of North Carolina Eosinophilic Esophagitis (EoE)/EGID database who also had a diagnosis of comorbid autonomic dysfunction (postural orthostatic tachycardia syndrome [POTS] or gastroparesis). The electronic medical record was abstracted and disease characteristics summarized.
Results: We identified seven patients who had EGID and autonomic dysfunction. All had POTS and were Caucasian, and five (71%) were female; 2 also had gastroparesis. Onset of autonomic symptoms coincided with onset of EGID symptoms in 3 patients (43%) or with an acute EGID flare in 3. In no cases did successful control of EGID lead to improvement of autonomic symptoms. Two subjects (29%) had comorbid Ehlers-Danlos syndrome and mast cell activation syndrome. The prevalence of POTS in EGID patients was 7/560 (1.25%), compared to an estimated 0.17% prevalence of POTS in the general population.
Conclusions: The prevalence of autonomic dysfunction was 5-10-fold higher in EGID than expected in the general population, suggesting an association between the two conditions, though the underlying mechanism is unclear. Providers should consider comorbid autonomic dysfunction in patients with EGID, particularly when symptoms persist despite treatment.
Similar articles
-
Eosinophilic gastrointestinal diseases with esophageal involvement: Analysis of 212 patients.Med Clin (Barc). 2023 Nov 10;161(9):374-381. doi: 10.1016/j.medcli.2023.06.010. Epub 2023 Jul 29. Med Clin (Barc). 2023. PMID: 37524587 English, Spanish.
-
The Natural History of Eosinophilic Gastrointestinal Diseases Is Influenced by Age of Onset and Location of Involvement.Am J Gastroenterol. 2024 Sep 1;119(9):1813-1820. doi: 10.14309/ajg.0000000000002869. Epub 2024 May 16. Am J Gastroenterol. 2024. PMID: 38752626 Free PMC article.
-
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases.Clin Gastroenterol Hepatol. 2022 Apr;20(4):e664-e670. doi: 10.1016/j.cgh.2021.05.044. Epub 2021 May 28. Clin Gastroenterol Hepatol. 2022. PMID: 34058413 Free PMC article.
-
Eosinophilic Gastrointestinal Disorders.Clin Rev Allergy Immunol. 2019 Oct;57(2):272-285. doi: 10.1007/s12016-019-08732-1. Clin Rev Allergy Immunol. 2019. PMID: 30903439 Review.
-
Eosinophilic Gastrointestinal Diseases in Childhood.Ann Nutr Metab. 2018;73 Suppl 4:18-28. doi: 10.1159/000493668. Epub 2019 Feb 19. Ann Nutr Metab. 2018. PMID: 30783041 Review.
Cited by
-
Efficacy of Jianpiyangxue granule on gastrointestinal autonomic nerve dysfunction and its impact on adverse reactions.Am J Transl Res. 2021 Nov 15;13(11):12929-12938. eCollection 2021. Am J Transl Res. 2021. PMID: 34956508 Free PMC article.
-
Mast cell activation syndrome: Current understanding and research needs.J Allergy Clin Immunol. 2024 Aug;154(2):255-263. doi: 10.1016/j.jaci.2024.05.025. Epub 2024 Jun 6. J Allergy Clin Immunol. 2024. PMID: 38851398 Free PMC article. Review.
-
The Suggested Relationships Between Common GI Symptoms and Joint Hypermobility, POTS, and MCAS.Gastroenterol Hepatol (N Y). 2024 Aug;20(8):479-489. Gastroenterol Hepatol (N Y). 2024. PMID: 39205953 Free PMC article.
-
Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity.Front Immunol. 2024 Apr 8;15:1369295. doi: 10.3389/fimmu.2024.1369295. eCollection 2024. Front Immunol. 2024. PMID: 38650940 Free PMC article.
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical